Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat

Platanias, 1990, Interleukin-1: biology, pathophysiology, and clinical prospects, Am J Med, 89, 621, 10.1016/0002-9343(90)90181-C Dinarello, 1989, Interleukin-1 and its biologically related cytokines, Adv Immunol, 44, 143 Beutler, 1989, The biology of cachectin/ TNF-α primary mediator of the host response, Ann Rev Immunol, 7, 625, 10.1146/annurev.iy.07.040189.003205 Le, 1989, Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase response, Lab Invest, 61, 588 Dinarello, 1986, Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1, J Exp Med, 163, 1433, 10.1084/jem.163.6.1433 van Damme, 1987, Identification of the human 26-kD protein, interferon β2 (IFN β2) as a B cell hybridoma/plasmocytoma growth factor induced by interleukin 1 and tumor necrosis factor, J Exp Med, 165, 914, 10.1084/jem.165.3.914 Ulich, 1991, Endotoxin-induced cytokine gene expression in vivo. III. IL6 mRNA and serum protein expression and the in vivo hematologic effects of IL6, J Immunol, 146, 2316, 10.4049/jimmunol.146.7.2316 Han, 1990, Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/ tumor necrosis factor synthesis at separate points in the signaling pathway, J Exp Med, 172, 391, 10.1084/jem.172.1.391 Fong, 1989, Antibodies to cachectin/tumor necrosis factor reduce interleukin 1β and interleukin 6 appearance during lethal bacteremia, J Exp Med, 170, 1627, 10.1084/jem.170.5.1627 van Zee, 1991, IL-8 in septic shock, endotoxemia, and after IL-1 administration, J Immunol, 146, 3478, 10.4049/jimmunol.146.10.3478 Jablons, 1989, IL6/IFN-β2 as a circulating hormone. Induction by cytokine administration in humans, J Immunol, 142, 1542, 10.4049/jimmunol.142.5.1542 Marinkovic, 1989, IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo, J Immunol, 142, 808, 10.4049/jimmunol.142.3.808 Geiger, 1988, Induction of rat acute-phase proteins by interleukin 6 in vivo, Eur J Immunol, 18, 717, 10.1002/eji.1830180510 Gauldie, 1987, Interferon (β2/B-cell stimulatory factor type 2 shares identity with monocytes-derived hepatocytes-stimulating factor and regulates the major acutephase protein response in liver cells, 84, 7251 Klapproth, 1989, Fate and biological action of human recombinant interleukin-1β in the rat in vivo, Eur J Immunol, 19, 1485, 10.1002/eji.1830190821 Renton, 1983, Relationships between the enzymes of detoxication and host defense mechanisms, 307 Farrell, 1987, Drug metabolism in extrahepatic diseases, Pharmacol Ther, 35, 375, 10.1016/0163-7258(87)90101-X Renton, 1976, Depression of hepatic cytochrome P-450 dependent monoxygenase systems with administered interferon inducing agents, Biochem Biophys Res Commun, 73, 343, 10.1016/0006-291X(76)90713-0 Descotes, 1985, Immunomodulating agents and hepatic drug-metabolizing enzymes, Drug Metab Rev, 16, 175, 10.3109/03602538508991434 Williams, 1985, Induction of tolerance in mice and rats to the effect of endotoxin to decrease the hepatic microsomal mixed-function oxidase system. Evidence for a possible macrophage-derived factor in the endotoxin effect, Int J Immunopharmacol, 7, 501, 10.1016/0192-0561(85)90069-4 Gorodischer, 1976, Hepatic microsomal drug metabolism after administration of endotoxin in rats, Biochem Pharmacol, 25, 351, 10.1016/0006-2952(76)90226-4 Ghezzi, 1986, Role of interleukin-1 in the depression of liver drug metabolism by endotoxin, Infect Immun, 54, 837, 10.1128/IAI.54.3.837-840.1986 Ghezzi, 1986, Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice, Biochem Biophys Res Commun, 136, 316, 10.1016/0006-291X(86)90912-5 Shedlofsky, 1987, Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice, Life Sci, 40, 2331, 10.1016/0024-3205(87)90506-6 Bertini, 1988, Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: a comparison with lymphotoxin and interferon, Int J Immunopharmacol, 10, 525, 10.1016/0192-0561(88)90069-0 Bertini, 1989, Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron, J Leukocyte Biol, 46, 254, 10.1002/jlb.46.3.254 Pous, 1990, Effect of recombinant human interleukin-1β and tumor necrosis factor α on liver cytochrome P-450 and serum α-1-acid glycoprotein concentrations in the rat, Drug Metab Dispos, 18, 467 Sujita, 1990, Effect of interleukin 1 (IL-1) on the levels of cytochrome P-450 involving IL-1 receptor on the isolated hepatocytes of rat, Biochem Biophys Res Commun, 168, 1217, 10.1016/0006-291X(90)91158-O Baumann, 1991, Molecular cloning, characterization and functional expression of the rat liver interleukin 6 receptor, J Biol Chem, 265, 19853, 10.1016/S0021-9258(17)45451-2 Nebert, 1989, The P-450 superfamily: updated listing of all genes and recommended no-menclature for the chromosomal loci, DNA, 1, 1, 10.1089/dna.1.1989.8.1 Baumann, 1989, Alpha-1-acid glycoprotein. Genetics, biochemistry, physiological functions, and pharmacology, Vol. 300 Kremer, 1988, Drug binding to human alpha-1-acid glycoprotein in health and disease, Pharmacol Rev, 40, 1 Chauvelot-Moachon, 1988, Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital, J Pharmacol Exp Ther, 244, 1103 Cresteil, 1979, Effects of microsomial preparations and induction on cytochrome P-450-dependent monooxygenases in fetal and neonatal rat liver, Biochem Pharmacol, 28, 2057, 10.1016/0006-2952(79)90224-7 Omura, 1964, The carbon monoxide-pigment of liver microsomes. I. Evidence for its hemoprotein nature, J Biol Chem, 239, 2370, 10.1016/S0021-9258(20)82244-3 Ullrich, 1972, The O-dealkylation of 7-ethoxycoumarin by liver microsomes, Hoppe Seylers Z Physiol Chem, 353, S1171, 10.1515/bchm2.1972.353.2.1171 Burke, 1974, Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrène, Drug Metab Dispos, 2, 583 Nakanishi, 1971, Kinetic studies for aniline hydroxylase after prolonged ethanol treatment, Jpn J Pharmacol, 21, 303, 10.1254/jjp.21.303 Anders, 1966, Inhibition of drug metabolism. Kinetics of the inhibition of the N-demethylation of ethylmorphine by 2-ethylaminoethyl-2,2-dephenylvalerate HCl (SKF-525 A) and related compounds, Mol Pharmacol, 2, 319 Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 272, 680, 10.1038/227680a0 Burnette, 1981, Western-blotting electrophoretic transfer of proteins from sodium dodecylsulfate polyacrylamide gels to immodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A, Anal Biochem, 12, 195, 10.1016/0003-2697(81)90281-5 Beaune, 1985, Monoclonal antibodies against human liver cytochrome P-450, Biochem Pharmacol, 34, 3547, 10.1016/0006-2952(85)90732-4 Souhaili-El-Amri, 1988, Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics, Toxicol Appl Pharmacol, 92, 141, 10.1016/0041-008X(88)90236-0 Lowry, 1951, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 Mortensen, 1988, Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of acute phase proteins, J Immunol, 140, 2260, 10.4049/jimmunol.140.7.2260 Prowse, 1988, Hepatocyte-stimulating factor, β2 interferon, and interleukin-1 enhance expression of the rat α1-acid glycoprotein gene via a distal upstream regulatory region, Mol Cell Biol, 8, 42, 10.1128/MCB.8.1.42 Fong, 1989, Endotoxinemia elicits increased circulating β2-IFN/IL2 in man, J Immunol, 142, 2321, 10.4049/jimmunol.142.7.2321 Hirano, 1991, Biological and clinical aspects of interleukin 6, Immunol Today, 11, 443, 10.1016/0167-5699(90)90173-7 Stanley, 1991, Differential effects of recombinant interferon α on constitutive and inducible cytochrome P450 isozymes in mouse liver, Biochem Pharmacol, 42, 311, 10.1016/0006-2952(91)90718-K Craig, 1990, Interferon down regulates the male-specific cytochrome P450 IIIA 2 in rat liver, Mol Pharmacol, 38, 313 Gresser, 1987, Tumor necrosis factor induces acute phase proteins in rats, J Biol Regul Homeostatic Agents, 1, 173 Boraschi, 1988, In vivo stimulation and restoration of the immune response by the non-inflammatory fragment 163–171 of human interleukin 1β, J Exp Med, 168, 675, 10.1084/jem.168.2.675 Wright, 1991, Regulation of cytochrome P450IIC12 expression by interleukin 1 α, interleukin-6, and dexamethasone, Mol Pharmacol, 39, 468 Baumann, 1987, Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells, J Biol Chem, 262, 9756, 10.1016/S0021-9258(18)47999-9 Peterson, 1986, The role of lymphocytes, macrophages and interferon in the depression of drug metabolism by dextran sulfate, Immunopharmacology, 11, 21, 10.1016/0162-3109(86)90061-5 Bryden, 1991, Depression of cyt P450 by inflammatory mediators, 108 Williams, 1991, Effect of interleukin 6 on phenobarbital induction of cytochrome P-450IIB in cultured hepatocytes, Biochem Biophys Res Commun, 178, 1049, 10.1016/0006-291X(91)90998-M Sinclair, 1991, Induction of cytochrome P-450 aminolevulinate synthase activities in cultured rat hepatocytes, Cancer Res, 50, 5219 Snouwaert, 1991, Effects of site-specific mutations on biologic activities of recombinant IL-6, J Immunol, 146, 585, 10.4049/jimmunol.146.2.585 Butler, 1989, Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention, Clin Immunol Immumpathol, 53, 400, 10.1016/0090-1229(89)90003-2 Castell, 1990, Fate of interleukin-6 in the rat. Involvement of skin in its catabolism, Eur J Biochem, 189, 113, 10.1111/j.1432-1033.1990.tb15466.x Bocci, 1991, Interleukins. Clinical pharmacokinetics and practical implications, Clin Pharmacokinet, 21, 274, 10.2165/00003088-199121040-00004 Houssiau, 1988, Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and the inflammatory arthritides, Arthritis Rheum, 31, 784, 10.1002/art.1780310614 Guerne, 1989, Inflammatory microcrystals stimulate interleukin 6 production and secretion by human monocytes and synoviocytes, Arthritis Rheum, 32, 1443, 10.1002/anr.1780321114 Alegre, 1991, Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone, J Immunol, 146, 1184, 10.4049/jimmunol.146.4.1184 Levine, 1989, Increased serum phenytoin concentration following influenza vaccine, Clin Pharm, 3, 505 Chang, 1978, Altered theophylline pharmacokinetics during respiratory viral illness, Lancet, i, 1132, 10.1016/S0140-6736(78)90305-7 Chindavijak, 1988, Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes, Pharmacology, 36, 279, 10.1159/000138395 Chindavijak, 1988, Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat, J Pharmacol Exp Ther, 246, 1075